Coming May 2025
Get Early Access
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Founded with the mission to revolutionize personal wellness, Vivoo offers a unique health monitoring solution through urinalysis test strips paired with a mobile application. The core vision is to empower individuals with actionable insights into their health, focusing on personalized nutrition advice derived from urine samples. Vivoo targets health-conscious consumers seeking convenient and accurate ways to monitor their well-being.
Vivoo has garnered attention from notable investors and health professionals who support its innovative approach to wellness. Among its key achievements, the company has successfully expanded its product line to include various test kits and secured free shipping to 40 countries, enhancing its global reach. Vivoo's impact lies in its ability to provide users with real-time, personalized health data, promoting proactive health management and better lifestyle choices.
Operating Status
Active
Ownership Type(s)
Venture Capital
Main Product(s)
Health Testing
Technology
Analytics
Tags
Healthtech
Model Types
eCommerce
Revenue Type(s)
Recurring
Customer Type(s)
Consumers
Geographic Exposure
Global
When was Vivoo founded?
Vivoo was founded in 2017.
Where is Vivoo's headquarters located?
Vivoo's headquarters is located in Palo Alto, CA, US.
When was Vivoo's last funding round?
Vivoo's most recent funding round was for $10M (USD) in August 2023.
How many employees does Vivoo have?
Vivoo has 68 employees as of Feb 4, 2024.
How much has Vivoo raised to-date?
As of July 05, 2023, Vivoo has raised a total of $18.4M (USD) since Aug 21, 2023.
Add Comparison
Total Raised to Date
$18.4M
USD
Last Update Aug 21, 2023
Last Deal Details
$10M
USD
Aug 21, 2023
Series B
Current Employees
68
Last updated: Feb 4, 2024
No location information available for this company.
Locations
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts